Trevena Inc (TRVN)
0.40
-0.01
(-2.20%)
USD |
NASDAQ |
Apr 26, 13:59
Trevena Enterprise Value: 5.327M for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 5.327M |
| April 24, 2024 | 4.814M |
| April 23, 2024 | 4.942M |
| April 22, 2024 | 4.616M |
| April 19, 2024 | 4.283M |
| April 18, 2024 | 4.540M |
| April 17, 2024 | 5.199M |
| April 16, 2024 | 5.034M |
| April 15, 2024 | 5.013M |
| April 12, 2024 | 4.822M |
| April 11, 2024 | 5.401M |
| April 10, 2024 | 5.272M |
| April 09, 2024 | 5.168M |
| April 08, 2024 | 5.369M |
| April 05, 2024 | 5.474M |
| April 04, 2024 | 5.089M |
| April 03, 2024 | 4.778M |
| April 02, 2024 | 4.637M |
| April 01, 2024 | 5.162M |
| March 28, 2024 | 6.262M |
| March 27, 2024 | 6.236M |
| March 26, 2024 | 5.956M |
| March 25, 2024 | 5.804M |
| March 22, 2024 | 6.262M |
| March 21, 2024 | 7.016M |
| Date | Value |
|---|---|
| March 20, 2024 | 7.542M |
| March 19, 2024 | 7.911M |
| March 18, 2024 | 7.911M |
| March 15, 2024 | 7.911M |
| March 14, 2024 | 8.167M |
| March 13, 2024 | 7.966M |
| March 12, 2024 | 8.134M |
| March 11, 2024 | 8.185M |
| March 08, 2024 | 8.356M |
| March 07, 2024 | 8.057M |
| March 06, 2024 | 8.458M |
| March 05, 2024 | 8.193M |
| March 04, 2024 | 8.642M |
| March 01, 2024 | 8.294M |
| February 29, 2024 | 8.478M |
| February 28, 2024 | 8.277M |
| February 27, 2024 | 8.478M |
| February 26, 2024 | 8.414M |
| February 23, 2024 | 8.114M |
| February 22, 2024 | 8.244M |
| February 21, 2024 | 8.196M |
| February 20, 2024 | 8.262M |
| February 16, 2024 | 8.295M |
| February 15, 2024 | 9.184M |
| February 14, 2024 | 8.951M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-19.71M
Minimum
Mar 24 2023
411.96M
Maximum
Sep 29 2020
72.91M
Average
32.31M
Median
Dec 13 2019
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.275M |
| Palatin Technologies Inc | 18.27M |
| iBio Inc | 15.86M |
| Theriva Biologics Inc | -13.19M |
| Oragenics Inc | 3.172M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -16.53M |
| Revenue (Quarterly) | -0.082M |
| Total Expenses (Quarterly) | 10.06M |
| EPS Diluted (Quarterly) | -1.13 |
| Earnings Yield | -800.0% |
| Normalized Earnings Yield | -861.14 |